Design, synthesis and primary activity of thiomorpholine derivatives as DPP-IV inhibitors

Chinese Chemical Letters

Volumn 23, Issue 3, 2012, Pages 297-300

  Han, Bei ^a   Liu, Jing Long ^a   Huan, Yi ^a   Li, Peng ^a   Wu, Qi ^a   Lin, Zi Yun ^a   Shen, Zhu Fang ^a   Yin, Da Li ^a   Huang, Hai Hong ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Dipeptidyl peptidase IV inhibitor; Oral glucose tolerance test; Structure activity relationship; Synthesis; Thiomorpholine

Indexed keywords

EID: 84862829036     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2011.12.007     Document Type: Article

References (8)

1. L. Wang Foreign Med. Sci. Sect. Pharm. 29 2002 173
2. S.H. Havale, and M. Pal Bioorg. Med. Chem. 17 2009 1783
3. W. Gu, A.H. Nie, and S. Li Chin. J. Med. Chem. 14 2004 373
4. B. Han, Y. Huan, and Z.Y. Lin Acta Pharm. Sin. 45 2010 1379
5. J.W. Skiles, J.T. Suh, and B.E. Williams J. Med. Chem. 29 1986 784
6. R.M. Williams, and M.N. Im J. Am. Chem. Soc. 113 1991 9276
7. C.X. Hu, H. Huang, and L. Zhang Biotechnol. Lett. 31 2009 979
8. D.M. Evans, D.M. Ashworth, Inhibitors of Dipeptidyl Peptidase IV, WO 03035057, 2003-05-01.